Drugs Made In America Acquisition (DMII) Enterprise Value (2024 - 2025)
Drugs Made In America Acquisition (DMII) posted quarterly Enterprise Value of -$223.0 for Q4 2025, up 98.69% year-over-year from -$112.23 in Q4 2024, and up 99.93% quarter-over-quarter from -$315087.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) Enterprise Value (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has reported Enterprise Value for 2 consecutive years, with -$223.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value rose 98.69% year-over-year to -$223.0; the TTM figure through Dec 2025 stood at -$223.0 (up 98.69% YoY), while the FY2025 annual figure was -$223.0, up 98.69% from the prior year.
- Enterprise Value climbed to -$223.0 in Q4 2025 per DMII's latest filing, from -$315087.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$223.0 in Q4 2025 and bottomed at -$315087.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | -250,000.00 |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | -174,974.00 |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | -25,000.00 |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | -10,586.00 |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | -283,112.00 |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | -194,541.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | -250,000.00 |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | -32,560.00 |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | -147,000.00 |
| 10 | New Providence Acquisition Corp. III | 313.81 Mn | 313.81 Mn | - | -250,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -223.00 |
| Sep 30, 2025 | -315,087.00 |
| Dec 31, 2024 | -17,035.00 |